BIOA earnings date and last-quarter result: last quarter beat, P/E -9.14. Updated 2026-07-23.
BioAge Labs (BIOA) Research Hub
BioAge Labs (BIOA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 4.99 USD (-2.16%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.14, market cap 0.83B. This hub links to the full technical, earnings and options research available for BIOA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.99 USD (-2.16%) |
| 52-week range | 4.82 USD – 25.96 USD |
| Trend regime | Range |
| 14-day RSI | 28.6 (Oversold) |
| Trailing P/E | -9.14 |
| Market cap | 0.83B |
| Dividend yield | 0.00% |
Available research for BIOA
Covered Call on BIOA: how it works, illustrative setup around the real 4.99 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BIOA: how it works, illustrative setup around the real 4.99 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BIOA: how it works, illustrative setup around the real 4.99 USD price, max profit/loss, breakeven and when to use it. Educational.
BIOA technical analysis: range, last 4.99 USD, RSI 28.6, 52w range 4.82 USD–25.96 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BIOA in?
BioAge Labs (BIOA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BIOA in an uptrend or downtrend?
As of 2026-10-26, BIOA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BIOA's trailing P/E ratio?
BIOA's trailing P/E is -9.14, with a market cap of 0.83B. See the earnings research page for full valuation detail.